Log in
Enquire now
Pepgen Limited

Pepgen Limited

Peptide Conjugation Technology for Gene Delivery

OverviewStructured DataIssuesContributors

Contents

pepgen.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Engineering
Engineering
Biomedical engineering
Biomedical engineering
Drug delivery
Drug delivery
Biotechnology
Biotechnology
0
Therapeutics
Therapeutics
0
Location
Boston, Lincolnshire
Boston, Lincolnshire
United Kingdom
United Kingdom
B2X
B2B
B2B
0
Legal classification
Private limited company
Private limited company
Date Incorporated
January 25, 2018
Number of Employees (Ranges)
51 – 2000
Full Address
Bioescalator Innovation Building, University Of Oxford Old Road Campus, Roosevelt Dr, Oxford, United Kingdom, OX3 7FZ
Incorporation Reference
11170794
Investors
CureDuchenne Ventures
CureDuchenne Ventures
University of Oxford
University of Oxford
RA Capital Management
RA Capital Management
OSI (Oxford Sciences Innovation)
OSI (Oxford Sciences Innovation)
Founded Date
2018
0
Total Funding Amount (USD)
157,499,887
Latest Funding Round Date
August 2021
Latest Funding Type
Series A
Series A
Country
United Kingdom
United Kingdom

Other attributes

Company Operating Status
Active
UKSIC Code
72110
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Pepgen Limited

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.